Antioxidants for hypertension
- 1 September 1998
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 7 (5) , 531-538
- https://doi.org/10.1097/00041552-199809000-00008
Abstract
Increasing evidence implicates reactive oxygen species in the pathogenesis of hypertension and its cardiovascular complications. By altering the balance in the endothelium between vasoconstrictors such as thromboxane and isoprostanes and vasodilators such as nitric oxide, reactive oxygen species contribute to endothelium-dependent contractions and increased vascular resistance. Antioxidants can restore endothelial function and decrease blood pressure in several models of hypertension and in some, but not all, studies of humans with essential hypertension. The potential of antioxidant therapy for hypertension is considerable.Keywords
This publication has 45 references indexed in Scilit:
- Cyclic Strain–Induced Reactive Oxygen Species Involved in ICAM-1 Gene Induction in Endothelial CellsHypertension, 1998
- Antioxidants and Atherosclerotic Heart DiseaseNew England Journal of Medicine, 1997
- Biochemistry and pathology of radical-mediated protein oxidationBiochemical Journal, 1997
- The importance of oxidative stress in apoptosisBritish Medical Bulletin, 1997
- Oxygen Free Radicals and Platelet ActivationFree Radical Biology & Medicine, 1997
- Superoxide anion and endothelial regulation of arterial toneFree Radical Biology & Medicine, 1996
- Free radicals and phagocytic cellsThe FASEB Journal, 1995
- Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.Circulation Research, 1994
- Cellular defenses against damage from reactive oxygen speciesPhysiological Reviews, 1994
- Drug Antioxidant EffectsDrugs, 1991